Source: Health Canada shortage reports · Updated Jul 9, 2026
Hydrochlorothiazide Triamterene products have been discontinued in Canada. See the reports below for which products and when.
A combination of two diuretics used to treat high blood pressure and fluid retention.
Products affected
0 / 3
Reports on file
15
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Resolved
APO TRIAZIDE
25MG
50MG · TABLET · APOTEX INC
DIN 00441775 · ended Apr 4, 2024 · Disruption of the manufacture of the drug.
Resolved
APO TRIAZIDE
25MG
50MG · TABLET · APOTEX INC
DIN 00441775 · ended Nov 9, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-TRIAMTERENE/HCTZ
25MG
50MG · TABLET · TEVA CANADA LIMITED
DIN 00532657 · ended Oct 11, 2023 · Disruption of the manufacture of the drug.
Resolved
APO TRIAZIDE
50MG
25MG · TABLET · APOTEX INC
DIN 00441775 · ended Jun 11, 2021 · Disruption of the manufacture of the drug.
Resolved
TEVA-TRIAMTERENE/HCTZ
50MG
25MG · TABLET · TEVA CANADA LIMITED
DIN 00532657 · ended Feb 17, 2021 · Disruption of the manufacture of the drug.
Resolved
APO TRIAZIDE
50MG
25MG · TABLET · APOTEX INC
DIN 00441775 · ended Dec 30, 2020 · Disruption of the manufacture of the drug.
Resolved
TEVA-TRIAMTERENE/HCTZ
50MG
25MG · TABLET · TEVA CANADA LIMITED
DIN 00532657 · ended May 8, 2020 · Item is discontinued
Discontinued
TEVA-TRIAMTERENE/HCTZ
50MG
25MG · TABLET · TEVA CANADA LIMITED
DIN 00532657
Resolved
TEVA-TRIAMTERENE/HCTZ
50MG
25MG · TABLET · TEVA CANADA LIMITED
DIN 00532657 · ended Apr 30, 2020 · Disruption of the manufacture of the drug.
Resolved
TEVA-TRIAMTERENE/HCTZ
25MG
50MG · TABLET · TEVA CANADA LIMITED
DIN 00532657 · ended Feb 12, 2020 · Disruption of the manufacture of the drug.
Discontinued
APO TRIAZIDE
50MG
25MG · TABLET · APOTEX INC
DIN 00441775
Resolved
APO TRIAZIDE
50MG
25MG · TABLET · APOTEX INC
DIN 00441775 · ended Feb 16, 2018 · Disruption of the manufacture of the drug.
Showing 12 of 15 reports. All reports are on file with Health Canada.
What's happening
One or more Hydrochlorothiazide Triamterene products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.
Hydrochlorothiazide Triamterene is classified under “DIURETICS AND POTASSIUM-SPARING AGENTS IN COMB” (ATC C03EA).
Recent changes
No changes recorded yet.
Common questions
What is Hydrochlorothiazide Triamterene used for?
A combination of two diuretics used to treat high blood pressure and fluid retention.
When will Hydrochlorothiazide Triamterene be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Hydrochlorothiazide Triamterene in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.